Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
battlefield
biotech ipos
boston
boston blog main
boston top stories
cancer
clinical trials
disease
disrupt sf 2017
dyne therapeutics
events
fda
health
life sciences
medicine
metacrine
myotonic dystrophy type 1
national blog main
nonalcoholic steatohepatitis
rare disease drugs
rare diseases
salk institute
san diego blog main
san diego top stories
startups
tc
ulcerative colitis
What
stage
2
×
available
brings
cancer
company
consequence
critical
day
despite
determining
developing
disorders
dozens
drug
dyne
dyne’s
genetic
great
guesswork
having
important
ipo
late
matters
medicines
million
miscalculate
muscle
muscular
ourotech
path
preclinical
prioritize
processes
pursuing
raised
rare
read
right
spent
Language
unset
Current search:
stage
×
biotech
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@techcrunch.com
6 years ago
Ourotech is taking the guesswork out of cancer treatment
